Literature DB >> 18461280

Pupillary function in early multiple sclerosis.

Jukka Surakka1, Juhani Ruutiainen, Anders Romberg, Pauli Puukka, Erkki Kronholm, Hannu Karanko.   

Abstract

Autonomic pupillary function was assessed with pupillometry in 95 mildly or moderately disabled patients with multiple sclerosis (MS) and 81 healthy subjects. The parasympathetic pupillary function was measured as initial diameter (mm), time to minimum diameter (seconds), reflex amplitude (mm), relative reflex amplitude (%), and maximal constriction velocity (mm/seconds). To reflect the sympathetic pupillary function maximal redilatation velocity (mm/seconds), and time of 75% of redilatation (seconds) were measured. Of MS patients 85-99% were within the reference values of healthy subjects. In MS patients the effect of age was observed in the initial diameter, reflex amplitude, and time of 75% redilatation. There were no such age related effects in healthy subjects. In age adjusted analysis the initial diameter and time of 75% redilatation differed significantly from healthy controls. Autonomic pupillary functions were not associated with fatigue, visual defect, or bladder disturbance, as measured by Fatigue Severity Scale, Kurtzke's Functional System Scales, Expanded Disability Status Scale, or the Multiple Sclerosis Functional Composite. Our results suggest that both parasympathetic and sympathetic pupillary functions are disturbed already early in the course of MS. However, the disturbance is not severe at this stage of the disease. The dysfunction is age-dependent and thus possibly related to the dimished remyelination capacity of the central nervous system.

Entities:  

Mesh:

Year:  2008        PMID: 18461280     DOI: 10.1007/s10286-008-0471-2

Source DB:  PubMed          Journal:  Clin Auton Res        ISSN: 0959-9851            Impact factor:   4.435


  19 in total

Review 1.  Pathology and pathogenesis of demyelinating diseases.

Authors:  M Storch; H Lassmann
Journal:  Curr Opin Neurol       Date:  1997-06       Impact factor: 5.710

2.  Effects of a 6-month exercise program on patients with multiple sclerosis: a randomized study.

Authors:  A Romberg; A Virtanen; J Ruutiainen; S Aunola; S-L Karppi; M Vaara; J Surakka; T Pohjolainen; A Seppänen
Journal:  Neurology       Date:  2004-12-14       Impact factor: 9.910

3.  Anhidrosis: a clue to an underlying autonomic disorder.

Authors:  Thomas Chemmanam; Jeyaraj D Pandian; Randhir S Kadyan; S M Bhatti
Journal:  J Clin Neurosci       Date:  2006-10-27       Impact factor: 1.961

4.  Pupillary disturbances in multiple sclerosis: correlation with MRI findings.

Authors:  J de Seze; C Arndt; T Stojkovic; M Ayachi; J Y Gauvrit; M Bughin; T Saint Michel; J P Pruvo; J C Hache; P Vermersch
Journal:  J Neurol Sci       Date:  2001-07-15       Impact factor: 3.181

5.  Age-related disability in multiple sclerosis.

Authors:  Maria Trojano; Maria Liguori; Giovanni Bosco Zimatore; Roberto Bugarini; Carlo Avolio; Damiano Paolicelli; Fabrizio Giuliani; Francesca De Robertis; Maria Giovanna Marrosu; Paolo Livrea
Journal:  Ann Neurol       Date:  2002-04       Impact factor: 10.422

6.  Effects of aerobic and strength exercise on motor fatigue in men and women with multiple sclerosis: a randomized controlled trial.

Authors:  Jukka Surakka; Anders Romberg; Juhani Ruutiainen; Sirkka Aunola; Arja Virtanen; Sirkka-Liisa Karppi; Kari Mäentaka
Journal:  Clin Rehabil       Date:  2004-11       Impact factor: 3.477

7.  Pupillary function in multiple sclerosis.

Authors:  J Jakobsen
Journal:  Acta Neurol Scand       Date:  1990-12       Impact factor: 3.209

8.  Pupillary light reflex latency in patients with multiple sclerosis.

Authors:  H A Van Diemen; M M Van Dongen; J J Nauta; P Lanting; C H Polman
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1992-03

9.  Portable infrared pupillometry using Pupilscan: relation to somatic and autonomic nerve function in diabetes mellitus.

Authors:  D M Levy; D A Rowley; R R Abraham
Journal:  Clin Auton Res       Date:  1992-10       Impact factor: 4.435

10.  Increased muscarinic cholinergic receptor density on CD4+ lymphocytes in progressive multiple sclerosis.

Authors:  B Anlar; J W Karaszewski; A T Reder; B G Arnason
Journal:  J Neuroimmunol       Date:  1992-02       Impact factor: 3.478

View more
  7 in total

1.  Pupil light reflex in Parkinson's disease patients with and without freezing of gait symptoms.

Authors:  Mosaad Alhassan; Jeffery K Hovis; Quincy J Almeida
Journal:  Saudi J Ophthalmol       Date:  2022-06-13

2.  In vivo detection of experimental optic neuritis by pupillometry.

Authors:  Kenneth S Shindler; Karen Revere; Mahasweta Dutt; Gui-Shuang Ying; Daniel C Chung
Journal:  Exp Eye Res       Date:  2012-04-24       Impact factor: 3.467

Review 3.  Autonomic Dysregulation in Multiple Sclerosis.

Authors:  Alexandra Pintér; Domonkos Cseh; Adrienn Sárközi; Ben M Illigens; Timo Siepmann
Journal:  Int J Mol Sci       Date:  2015-07-24       Impact factor: 5.923

4.  Subjective Cognitive Fatigue and Autonomic Abnormalities in Multiple Sclerosis Patients.

Authors:  Carina Sander; Helmut Hildebrandt; Hans-Peter Schlake; Paul Eling; Katrin Hanken
Journal:  Front Neurol       Date:  2017-09-13       Impact factor: 4.003

5.  Abnormal Dynamic Pupillometry Relates to Neurologic Disability and Retinal Axonal Loss in Patients With Multiple Sclerosis.

Authors:  Gulfidan Bitirgen; Zehra Akpinar; Huseyin B Turk; Rayaz A Malik
Journal:  Transl Vis Sci Technol       Date:  2021-04-01       Impact factor: 3.283

6.  Using System Identification to Construct an Inherent Model of Pupillary Light Reflex to Explore Diabetic Neuropathy.

Authors:  Yung-Jhe Yan; Chien-Nan Chen; Mang Ou-Yang
Journal:  Brain Sci       Date:  2021-06-25

7.  Fatigue and cognition: Pupillary responses to problem-solving in early multiple sclerosis patients.

Authors:  Sigrid A de Rodez Benavent; Gro O Nygaard; Hanne F Harbo; Siren Tønnesen; Piotr Sowa; Nils I Landrø; Marte Wendel-Haga; Lars Etholm; Kristian B Nilsen; Liv Drolsum; Emilia Kerty; Elisabeth G Celius; Bruno Laeng
Journal:  Brain Behav       Date:  2017-05-17       Impact factor: 2.708

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.